Generian team has developed an innovative approach to uncover first-in-class, gain-of-function drugs that activate key cellular networks linked to quality control and metabolism. Activation of these validated networks represents a unique approach with applicability across a broad range of chronic diseases. Led by top researchers in the fields ofaging, small molecule drug development, and E3 ubiquitin ligase biology, Generian's platform will transform how we treat a wide array of both rare and common conditions using small molecules to reset and restore cellular homeostasis.

Health Care

Pharmaceutical

Generian

Generian's headquarters in Pittsburgh, PA, United States

Description

People (3)

Hank Safferstein

Toren Finkel

Molly Curran

Jobs